Advanced Medical Solutions earnings to be impacted by sterilisation failure
Advanced Medical Solutions on Friday warned that its full-year earnings could take a £2.0m hit due to a sterilisation failure at one of its third party partners.
Advanced Medical Solutions Group
183.60p
16:45 19/04/24
FTSE AIM 100
3,595.66
17:08 19/04/24
FTSE AIM 50
3,943.93
17:08 19/04/24
FTSE AIM All-Share
745.67
17:08 19/04/24
Health Care Equipment & Services
11,690.05
17:09 19/04/24
As a result, many of the December orders for the surgical and advanced woundcare specialist's Liquiband topical adhesive product will not be sterilised and shipped to customers during the financial year ending 31 December 2019.
The unnamed supplier expects to resume operations in January, at which point the backlog will be addressed.
The company added that it did not expect any significant impact on end user sales due to the inventories held by its key customers.
Advanced Medical Solutions shares were down 2.63% at 259.00p at 1055 GMT.